Список литературы

  1. Amador-Patarroyo et al., “How Does Age at Onset Influence the Outcome of Autoimmune Diseases?”, Autoimmunity Reviews, vol. 2012, pp. 1-8, 2011.
  2. Atlas, Deyo, “Evaluating and Managing Acute Low Back Pain in the Primary Care Setting”, JGIM , vol.16, pp.120-131, 2001.
  3. Baraliakos et al., “Efficiency of treatment with non-steroidal anti-inflammatory drugs according to currency recommendations in patients with radiographic and non-radiographic axial spondyloarthritis”, Rheumatology , vol. 56, pp. 95-102, 2016.
  4. Bello et al., “Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis”, Arthritis Research & Therapy , vol. 18:42, pp.1-7, 2016.
  5. Benjamin et al. “Disease Modifying Anti-Rheumatic Drugs (DMARD)”, StatPearls - NCBI Bookshel f, pp. 1-5, 2020.
  6. Boonen et al., “The burden of non-radiographic axial spondyloarthris”, Seminars in Arthritis and Rheumatism , vol. 44, pp. 556-562, 2015.
  7. Centers for Disease Control and Prevention , National Center for Chronic Disease Prevention and Health Promotion , Division of Population Health , “Fibromyalgia?”, pp. 1-7, 2020, https://www.cdc.gov/arthritis/basics/fibromyalgia.htm
  8. Chakrabarty et al., “Fibromyalgia”, American Academy of Family Physicians , vol. 76, pp. 247-254, 2007.
  9. Hay et al., “The Extent and Characteristics of Diagnostic Delay in axSpA: A Systematic Review”, Keele University School for Primary, Community and Social Care , vol. ii126, pp. 1-2, 2020.
  10. Danve, Deodhar, “Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities”, Clinical Rheumatology , vol. 38, pp. 625-634, 2019.
  11. First, Louie, “Targeting inflammatory pathways in axial spondyloarthritis”, Arthritis Research & Therapy , vol. 21, pp. 1-15, 2019.G
  12. Heuch, Ingrid, “Acute low back usually resolves quickly but persistent low back pain often persists”, Journal of Physiotherapy, vol. 59, pp. 127.
  13. Khmelinskii et al., “The Role of Imaging in Diagnosing Axial Spondyloarthris”, Frontiers in Medicine , vol. 5, pp. 1-11, 2018.
  14. Lassiter, Allam, “Inflammatory Back Pain”, StatPearls - NCBI Bookshelf , pp. 1-7, 2020, https://www.ncbi.nlm.nih.gov/books/NBK539753/?report=printable
  15. McVeigh, Cairns, “Diagnosis and management of ankylosing spondylitis”, BMJ , vol. 333, pp. 581-585, 2006.
  16. Mease et al., “Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry”, Arthritis Care & Research , vol. 70, pp. 1661-1670, 2018.
  17. Morrow, “Defining the Difference: What Makes Biologics Unique”, Biotechnology Healthcare , pp. 25-29, 2004.
  18. Myasoedova et al., “Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007”, Arthritis Rheum , vol. 62, pp.1-12, 2010.
  1. National Institutes of Health, “Low Back Pain”, vol. 20, pp. 1-24, 2020.
  2. Noureldin, Barkham, “The current standards of care and the unmet needs for axial spondyloarthritis”, Rheumatology , vol. 57, pp. vi10-vi17, 2018.
  3. Ortolan et al., “Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort”, Arthritis Research & Therapy, vol. 20, pp. 1-8, 2018.
  4. Protopopov, Poddubnyy, “Radiographic progression in non-radiographic axial spondyloarthritis”, Expert Review of Clinical Immunolog y, vol. 14, pp. 525-533, 2018.
  5. Rubin, “Epidemiology and Risk Factors for Spine Pain”, Neurol Clin , vol. 25, pp. 353-371, 2007.
  6. Rudwaleit et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection”, Ann Rheum Dis , vol. 68, pp. 777-783, 2009.
  7. Rusman et al., “Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky”, Current Rheumatology Report s, vol. 20:35, pp. 1-12, 2018.
  8. Sieper, Rudwaleit, “Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care”, Ann Rheum Dis , vol. 64, pp. 659-663, 2005.
  9. Sieper et al., “The IL-23--IL-17 pathways as a therapeutic target in axial spondyloarthritis”, Nature Reviews, vol. 15, pp. 747-757, 2019.
  10. Smith, Germolec, “Introduction to Immunology and Autoimmunity”, Environmental Health Perspectives , vol. 107, pp. 661-665,1999.
  11. Strand, Singh, “Patient Burden of Axial Spondyloarthritis”, J Clin Rheumatol , vol. 23, pp. 383-391, 2017.
  12. Strand, Singh, “Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease”, Mayo Clinic , vol. 92, pp. 555-564, 2017.
  13. Torgutalp, Poddubnyy, “IL-17 inhibition in axial spondyloarthritis: current and future perspectives”, Expert Opinion on Biological Therapy , vol. 19, pp. 631-641, 2019.
  14. Wadeley et al., “Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood”, Clinical Rheumatology , vol. 37, pp. 1045-1052, 2018.
  15. Weisman, “Inflammatory Back Pain”, Rheum Dis Clin North Am ., vol. 38, pp. 501-512, 2012.
  16. Weisman, “The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10”, Ann Rheum Dis , vol. 72, pp. 369-373, 2013.
  17. Yi et al., “ Clinical, Economic, and Humanistic Burden Associated with Delayed Diagnosis of Axial Spondyloarthritis: A Systemic Review”, Rheumatol Ther, 2020 Mar;7(1):65-87. https://spondylitis.org/about-spondylitis/types-of-spondylitis/ankylosing-spondylitis/symptoms/
    https://my.clevelandclinic.org/health/diseases/4879-acute-mechanical-back-pain